Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darinaparsin in relapsed/refractory PTCL
NCT02653976Phase 2Completed
- Sponsor
- Solasia Pharma
- Start
- Mar 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of darinaparsin in peripheral T-cell lymphoma (PTCL), sponsored by Solasia Pharma. Started Mar 2016; status: completed.
02
Drugs
darinaparsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02653976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653976.